We are live on
!
Find out more
Dianthus Therapeutics
DNTH
DNTH
94 hedge funds and large institutions have $211M invested in Dianthus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 20
1% more funds holding
Funds holding: 93 → 94 (+1)
1.03% more ownership
Funds ownership: 4.04% → 5.07% (+1%)
6% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 16
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $276M → $211M (-$64.5M)
94% less call options, than puts
Call options by funds: $3K | Put options by funds: $52K
Holders
94
Holders Change
+1
Holders Change %
+1.08%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
26
Reduced
20
Closed
16
Calls
$3K
Puts
$52K
Net Calls
-$49K
Net Calls Change
-$135K
Top Buyers
| 1 |
Millennium Management
New York
|
+$4.29M |
| 2 |
O
OrbiMed
New York
|
+$2.25M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$718K |
| 4 |
BL
Bleichroeder LP
New York
|
+$314K |
| 5 |
State Street
Boston,
Massachusetts
|
+$259K |
Top Sellers
| 1 |
UBS AM
Chicago,
Illinois
|
-$3.72M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.48M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$2.79M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.58M |
| 5 |
EP
Eversept Partners
New York
|
-$1.45M |
